30 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Pharma Stocks Rally on Sanofi, GSK Coronavirus Vaccine Tie-Up http://www.zacks.com/stock/news/871951/pharma-stocks-rally-on-sanofi-gsk-coronavirus-vaccine-tie-up?cid=CS-ZC-FT-analyst_blog|industry_focus-871951 Apr 15, 2020 - If successful, the Sanofi (SNY) and GlaxoSmithKline plc (GSK) vaccine would be available in the second half of 2021. Shares of drugmakers jumped on the news.
Top Stock Reports for Microsoft, Walmart & Amgen http://www.zacks.com/research-daily/872353/top-stock-reports-for-microsoft-walmart-amgen?cid=CS-ZC-FT-research_daily-872353 Apr 15, 2020 - Top Stock Reports for Microsoft, Walmart & Amgen
Gilead's (GILD) Coronavirus Drug Shows Promise, Shares Gain http://www.zacks.com/stock/news/876070/gileads-gild-coronavirus-drug-shows-promise-shares-gain?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-876070 Apr 17, 2020 - Treatment with Gilead's (GILD) experimental antiviral, remdesivir, shows rapid recoveries in fever and respiratory symptoms in COVID-19 patients in a Chicago hospital.
Biotech ETF (BBH) Hits New 52-Week High http://www.zacks.com/stock/news/880288/biotech-etf-bbh-hits-new-52-week-high?cid=CS-ZC-FT-etf_news_and_commentary-880288 Apr 20, 2020 - This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?
Roche (RHHBY) Q1 Sales Grow on Solid Performance of New Drugs http://www.zacks.com/stock/news/883666/roche-rhhby-q1-sales-grow-on-solid-performance-of-new-drugs?cid=CS-ZC-FT-analyst_blog|earnings_article-883666 Apr 22, 2020 - Solid sales of Roche's (RHHBY) new drugs in the first quarter more than offset the competition from biosimilars.
Will Pfizer's (PFE) BioPharma Unit Q1 Earnings Increase? http://www.zacks.com/stock/news/887532/will-pfizers-pfe-biopharma-unit-q1-earnings-increase?cid=CS-ZC-FT-analyst_blog|earnings_preview-887532 Apr 24, 2020 - In Pfizer's (PFE) Biopharma unit, oncology sales are likely to have risen in the first quarter, while in non-oncology, Xeljanz and Eliquis alliance revenues are likely to have supported the top line.
Remdesivir Gets Emergency Approval: What's In Store for Gilead? http://www.zacks.com/stock/news/912891/remdesivir-gets-emergency-approval-whats-in-store-for-gilead?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-912891 May 04, 2020 - In a short span of time, Gilead's Remdesivir has been successful in treating some coronavirus patients. But will this give a boost to the pharmaceutical giant?
Stock Market News for Aug 26, 2020 http://www.zacks.com/stock/news/1047384/stock-market-news-for-aug-26-2020?cid=CS-ZC--market_news-1047384 Aug 26, 2020 - The S&P 500 and the Nasdaq hit an all-time high on Tuesday, while the Dow declined amid mixed economic news and decline in heavy weights like Exxon Mobil and Boeing.
Stock Market News for Sep1, 2020 http://www.zacks.com/stock/news/1050805/stock-market-news-for-sep1-2020?cid=CS-ZC--market_news-1050805 Sep 01, 2020 - U.S. stock markets closed mostly lower on Monday as investors booked profit after a week-long rally.
Trump's Pep Talk Raises Vaccine Hopes: 4 Stocks to Watch http://www.zacks.com/stock/news/1060885/trumps-pep-talk-raises-vaccine-hopes-4-stocks-to-watch?cid=CS-ZC-FT-analyst_blog|industry_focus-1060885 Sep 21, 2020 - Biotech firms and drugmakers across the globe are pumping in millions of dollars to develop a vaccine to wipe out the deadly coronavirus.

Pages: 123

<<<Page 3